Pharmaxis (OTCMKTS:PXSLY) and Blueprint Medicines (NASDAQ:BPMC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 100.0% of Blueprint Medicines shares are owned by institutional investors. 3.2% of Blueprint […]
